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Abstract Profilin II dimers bind the (GP5)3 peptide derived
from VASP with an affinity of approximately 0.5 WM. The
resulting profilin II-peptide complex overcomes the combined
capacity of thymosin L4 and profilin II to inhibit actin nucleation
and restores the extent of filament formation. We do not observe
such an effect when barbed filament ends are capped. Neither can
profilin I, in the presence of the peptide, promote actin
polymerization during its early phase consistent with a lower
affinity. Since a Pro17 peptide-profilin II complex only partially
restores actin polymerization, the glycine residues in the VASP
peptide appear important.
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1. Introduction
Certain types of cell movement are characterized by a rapid
spatially de¢ned turnover of the micro¢lament system upon
stimulation of cells. Actin desequestration and F-actin polym-
erization occur close to the cell membrane [1^3] or for in-
stance in the comet tails formed by Listeria [4]. A variety of
proteins are involved in this assembly and disassembly mech-
anism of actin, two of these key proteins are thymosin L4 and
pro¢lin.
Pro¢lin is a 12^15 kDa protein present in all eukaryotic
cells at concentrations in a range of 5U1036 to 5U1035 M.
Several ligands for pro¢lin were identi¢ed and can be classi-
¢ed into four di¡erent categories : actin [5], poly(L-proline)
and poly(L-proline) containing sequences [6,7], L-K-phospha-
tidylinositol 4,5-bisphosphate (PIP2) [8,9] and a complex of
proteins containing actin related proteins [10,11]. Families of
proteins containing proline rich sequences are known. Repre-
sentatives of the Ena/VASP family are the focal adhesion
proteins VASP [12,13] and the mammalian homologue of
Ena, known as Mena [14,15]. The formin homology protein
group consists of Saccharomyces cerevisiae Bni1p and Bnr1p
[16,17], Schizosaccharomyces pombe cdc12p [18], cappuccino
from Drosophila melanogaster [19,20], the mammalian homo-
logue of the Drosophila protein diaphanous, p140mDia, [21^
23], the Schizosaccharomyces pombe gene fus [20,24], the As-
pergillus nidulans gene ¢gA [25] and the members of the verte-
brate limb deformity complex [26].
Pro¢lin I was ¢rst identi¢ed as a G-actin sequestering agent
[5]. However its function is more complex, it also lowers the
steady state concentration of G-actin by the addition of pro-
¢lin I-ATP-G-actin complexes onto the barbed end of the F-
actin ¢lament [27^29]. It is believed this association is fol-
lowed by ATP hydrolysis resulting in the release of pro¢lin
I from the barbed end caused by a reduction in a⁄nity of
pro¢lin for the terminal subunits [30]. In the presence of thy-
mosin L4, the main G-actin sequestering agent in cells, pro¢lin
I promotes desequestration of G-actin from the thymosin L4-
G-actin pool [29]. When equilibrium between G- and F-actin
is reached in vitro and thymosin L4 is present the deseques-
tration activity of pro¢lin I has a much greater impact on
actin polymerization than its sequestration activity. Under
non-equilibrium conditions in vitro, pro¢lin I decelerates the
nucleation step of actin polymerization. The phenomena de-
scribed above obviously only take place when the barbed
¢lament ends are free. If the barbed ends of the F-actin ¢la-
ments are capped (for instance by gelsolin), pro¢lin I displays
a pure G-actin sequestering activity [28^30].
Mammalians have two pro¢lin isoforms, pro¢lin I and II
[31^34]. Both form a 1:1 complex with G-actin and have a
similar Kd value of approximately 0.5 WM [29,34]. In contrast,
their a⁄nity for their other ligands is quite di¡erent. Whereas
pro¢lin I is preferentially associated with PIP2, pro¢lin II dis-
plays a higher a⁄nity for poly(L-proline) rich sequences
[34,35].
In this paper we studied the interaction of the pro¢lin iso-
forms with proline peptides derived from VASP using Biacore
experiments and the e¡ect of pro¢lin II complexed to this
peptide on the polymerization of actin using £uorimetric as-
says. The results of our Biacore experiments indicate that
pro¢lin II dimerizes upon binding to the peptVASPwt peptide
and that the a⁄nity of this pro¢lin isoform for this peptide is
much higher in comparison to the a⁄nity of pro¢lin I. With
our £uorimetric measurements we prove that the interaction
of pro¢lin II with the peptVASPwt peptide overcomes the
combined capacity of pro¢lin II and thymosin L4 to inhibit
actin nucleation. Under the conditions used, this positive ef-
fect on actin polymerization is only observed for pro¢lin II
and not for pro¢lin I. It is neither observed when the barbed
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ends of the actin ¢lament are capped by gelsolin, in this case
the pro¢lin II-peptVASPwt complex merely sequesters G-ac-
tin.
2. Materials and methods
2.1. Protein preparation and peptide synthesis
We puri¢ed skeletal muscle actin from rabbit muscle [36] and iso-
lated it as calcium G-actin by Sephadex G200 chromatography [37] in
G-bu¡er (5 mM Tris-HCl pH 7.7, 0.1 mM CaCl2, 0.2 mM ATP, 0.2
mM dithiothreitol, 0.01% sodium azide). Cys-375 pyrene labeled actin
was prepared as described previously by Brenner and Korn [38]. We
isolated pro¢lin I and II from bovine spleen and brain respectively, as
described previously [34,39,40]. We dialyzed pro¢lin against HBS
bu¡er (10 mM HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA,
0.005% v/v surfactant P20, Pharmacia) for use in the Biacore experi-
ments or against G-bu¡er for the £uorimetric assays. We prepared
human plasma gelsolin following the procedure of Bryan [41].
We chemically synthesized thymosin L4 and poly(L-proline) pep-
tides on a model 431A peptide synthesizer (Applied Biosystems Inc.,
Foster City, CA, USA), and puri¢ed them using reversed phase
HPLC. We used electrospray mass spectrometry to assess the
mass and purity of the synthesized peptides. The proline peptides
used in the £uorimetric assays had the following sequences:
Ac.GP5GP5GP5GL (peptVASPwt) and Ac.GGP5GL (peptVASPs),
both derived from the VASP sequence, and a mutant peptide,
Ac.CGP17GL (peptVASP(G/P)), in which the glycines are substituted
by prolines. The analogous peptides used in the Biacore experiments,
have an amino terminal cysteine. The latter amino acid was biotiny-
lated with EZ-LinkIodoacetyl-LC-Biotin (Pierce). The biotinylated
peptide was puri¢ed by reversed phase HPLC.
2.2. BIACORE experiments
We determined the a⁄nity and stoichiometry of the pro¢lin-peptide
interaction using a BIACORE X (Pharmacia) with two £ow cells. We
immobilized, by non-covalent capture, biotinylated peptide (the li-
gand) on a streptavidin coated sensor chip (Pharmacia) in the ¢rst
£ow cell using a £ow of 5 Wl/min HBS bu¡er (Pharmacia). Di¡erent
concentrations of pro¢lin (the analyte) were passed over the sensor
chip at 20 Wl/min HBS bu¡er. We chose this £ow rate to exclude
concentration e¡ects due to mass transport limitations and to mini-
mize the bu¡er jump. The second £ow cell was used as the reference
cell. The interaction between analyte and ligand was monitored as a
kinetic curve (being the subtraction of the curves in £ow cells one and
two) with an association, an equilibrium and a dissociation phase.
We used the following formula to interpret the results of the Bia-
core kinetic curves
RUmax Ma=Ml WRUlWS
RUmax is the maximum net increase of response units (RU), which
can be obtained at equilibrium when monitoring the interaction of
analyte with immobilized ligand on the sensor chip. RU1 is the net
increase of RUs in £ow cell one obtained at the end of the immobil-
ization procedure. Ma is the molecular mass of the analyte (pro¢lin I
or II, 14 970 Da and 14 943 Da, respectively), Ml is the molecular
mass of the ligand (biotinylated forms of peptide, peptVASPwt:
2343 Da and peptVASPs: 1313 Da and peptVASP(G/P): 2424 Da),
S is the number of binding sites for the interaction between analyte
and ligand.
From the Biacore kinetic curves, one can deduce the equilibrium
dissociation constant for the interaction between analyte and ligand,
Kd. It was proven theoretically that the Kd is that concentration of
analyte needed to cause a half maximum net RU increase at equi-
librium (RUmax/2).
2.3. Spectro£uorimetry
In our £uorimetric assays, we studied the polymerization of actin
(5.5% of the total actin concentration was pyrene labeled actin) in
combination with various proteins as a function of time using a Hi-
tachi F-4500 spectrophotometer (excitation and emission wavelength
were set at 365 nm and 388 nm respectively). Each time we started the
polymerization by adding F-bu¡er (G-bu¡er+0.1 M KCl+1 mM
MgCl2) to the reaction mixture (see Figs. 2 and 4 for compositions).
G-actin and thymosin L4 were pre-incubated at room temperature
before inducing polymerization. When present together, poly(L-pro-
line) peptides and pro¢lin were pre-incubated (at least 15 min) at
room temperature before incubating with G-actin or with the G-ac-
tin-thymosin L4 mixture. The actin used in all the measurements was
always pre-incubated at room temperature for an equal time so as to
exclude temperature e¡ects between the di¡erent assays. To obtain
capped actin nuclei we prepared gelsolin capped actin ¢laments which
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Fig. 1. Biacore binding curves indicate pro¢lin II binds as a dimer
to peptVASPwt. A: Pro¢lin II in HBS bu¡er was sent over the im-
mobilized peptide. The concentrations of pro¢lin II are in descend-
ing order, 44 WM, 30 WM, 20 WM, 12 WM, 8 WM, 6 WM, 4 WM,
2 WM, 1.5 WM, 1 WM, 0.5 WM, 0.35 WM and 0.25 WM. Association
starts at 0 s, dissociation at time 180 s. B: A similar experiment for
pro¢lin I, using concentrations of 120 WM, 73 WM, 50 WM, 35 WM
and 25 WM. Note the di¡erence in reaction rates between the two
pro¢lin isoforms for their interaction with the immobilized peptide.
C: Plot of RU/pro¢lin II concentration versus RU at time 175 s,
from the data in A, suggesting the existence of multiple binding
events (for details see [65]).
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were diluted into G-actin (5.5% pyrene labeled) to a ¢nal concentra-
tion of 10 WM actin and 40 nM gelsolin for each sample. Various
proteins, with or without peptVASPwt, were then incubated with the
actin sample in the same way as described above (see Fig. 5). Polymer-
ization was started by adding F-bu¡er.
Additionally, we carried out £uorimetric measurements at steady
state. F-actin (7% pyrene labeled) was capped with gelsolin (1:330)
and diluted into F-bu¡er alone or into F-bu¡er with 3 WM pro¢lin or
into F-bu¡er with 3 WM pro¢lin and 3 WM of the peptVASPwt, to
obtain a concentration range of actin from 0 WM to 6 WM. The
samples were incubated overnight at room temperature in the dark
to reach steady state. By measuring the pyrene £uorescence, the
amount of unpolymerized actin was determined [29]. For another
experiment at steady state we incubated 4 WM F-actin (5.5% pyrene
labeled) capped with gelsolin (1:330), with a concentration range of
the VASP peptide (0^100 WM ¢nal concentration) in the absence and
in the presence of 3 WM pro¢lin II.
3. Results
3.1. Stoichiometry and equilibrium dissociation constant of the
interaction between the poly(L-proline) peptide of VASP
and pro¢lin
We immobilized biotinylated peptVASPwt on the sensor
chip to a level of 87 response units (RU). We monitored the
kinetics of the interactions with this peptide using a concen-
tration range of pro¢lin II (0.25 WM^44 WM) in HBS bu¡er
(Fig. 1A). The binding curves at the higher concentrations
converge between 1000 and 1100 RU indicating the maximum
level of response (RUmax) is approached and suggesting a
stoichiometry of two pro¢lin II molecules for one pept-
VASPwt (RUmaxt = 1110 for S = 2, see Table 1). A plot of
RU/pro¢lin concentration versus RU (at time 175 s) (Fig. 1C)
also indicates the existence of multiple binding events as no
linear curve can be drawn through the data points. The curve
approaches the X-axis at 1051 RU, close to the theoretically
expected value of RUmaxt for a stoichiometry of two to one.
At present we cannot exclude there is a third binding event
with lower a⁄nity but we note that in that case RUmaxt
would have to be 1664 RU. The global Kd value derived
from the Biacore binding curves, i.e. that concentration yield-
ing RUmax/2, is 0.5 WM.
We performed the same analysis for pro¢lin I, we immobi-
lized 60 RU of biotinylated peptVASPwt and we used a con-
centration range of 25^120 WM pro¢lin I (Fig. 1B). In this
case the results are less unambiguous because of a rather low
response even at high pro¢lin concentrations. Two scenarios
are possible for interpreting the interaction curves (Table 1). If
only a 1:1 complex can be formed, the theoretical RUmax is
384 RU. RUmax/2 is then reached at about 50 WM pro¢lin I,
and this would be approximately the equilibrium dissociation
constant. In contrast, if a 2:1 complex is formed, RUmaxt is
767 RU and RUmax/2 is not reached at 120 WM pro¢lin I.
Consequently the Kd must then be higher and this result is
more consistent with those of Petrella et al. [42], who deter-
mined a Kd of 500 WM for pro¢lin I when studying the inter-
action of pro¢lin I with a slightly shorter poly(L-proline) pep-
tide, and with the crystal structure of pro¢lin I in complex
with a proline peptide [43]. Thus, we can expect dimerization
is also taking place but with a much higher equilibrium dis-
sociation constant compared to pro¢lin II.
The steepness of the curves is an indication of the funda-
mentally di¡erent reaction rates for the two pro¢lin isoforms.
The association and dissociation rate constants of the inter-
action of peptVASPwt with pro¢lin I are much higher in
comparison to the interaction with pro¢lin II. From the
curves, one can in theory also derive the value of the associ-
ation and dissociation rate of the interaction. However, in the
current Biacore software (version 3.0), a model for describing
the multiple or co-operative binding of two identical analytes
to one ligand is not available.
We also performed analogous Biacore experiments using
other forms of biotinylated proline rich peptides and pro¢lin
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Table 1
Summary of the Biacore experiments with the di¡erent proline rich peptides and pro¢lins
PeptVASPwt PeptVASPs PeptVASP(G/P)
Ac.CGP5GP5GP5GL Ac.CGGP5GL Ac.CGP17GL
RUcoupled 87 RU 60 RU 67 RU 60 RU
Pro¢lin II Pro¢lin I Pro¢lin II Pro¢lin II
RUmaxt (S = 1) 555 RU 384 RU 763 RU 370 RU
RUmaxt (S = 2) 1110 RU 767 RU 740 RU
RU at [prof] 1052 RU at 44 WM 307 RU at 120 WM 52 RU at 35 WM 545 RU at 19 WM
RU at [prof] 545 RU at 0.5 WM 182 RU at 50 WM 183 RU at 1.9 WM (did not reach equilibrium)
Peptides were immobilized on the sensor chip to the indicated response units level (RUcoupled). RUmaxt is the calculated maximal response at a
given stoichiometry (S) of pro¢lin molecules. RU is the experimentally obtained value by sending pro¢lin (I or II), at the indicated concentration,
over the peptide on the chip.
Fig. 2. The pro¢lin II-peptVASPwt complex restores actin polymer-
ization in the presence of thymosin L4 when barbed ends are free.
We monitored the polymerization of either 10 WM actin alone (5.5%
pyrene labeled) (curve A, R), with 10 WM thymosin L4 (curve B,
U), with 10 WM thymosin L4 and 5 WM pro¢lin II (curve C, E),
with 10 WM thymosin L4, 5 WM pro¢lin II and 5 WM peptVASPwt
(curve D, F), with 10 WM thymosin L4, 5 WM pro¢lin II and 5 WM
of the short peptVASPs (curve E, W), or with 10 WM thymosin L4,
5 WM pro¢lin II and 5 WM of the mutant peptVASP(G/P) (curve F,
+). The inset shows the early nucleation phase for curves A and D
only.
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II. We immobilized either a shorter peptide, peptVASPs, hav-
ing only one GP5 sequence instead of three repeats, or the
peptVASP(G/P) peptide with the same length as the pept-
VASPwt but in which the glycine residues were substituted
by prolines. We found a much lower a⁄nity of pro¢lin II
for the short peptide (Table 1). When a relatively high con-
centration of pro¢lin II was sent over the immobilized peptide
only a small signal in comparison to the maximal possible
response, was monitored. The peptide without glycine residues
has a reasonably high a⁄nity for pro¢lin II because 19 WM of
pro¢lin II causes a signal close to the theoretical maximal
response.
3.2. The interaction between pro¢lin II and the poly(L-proline)
peptide of VASP overcomes the sequestering activity of
thymosin L4
The observation that pro¢lin II dimerizes upon binding
peptVASPwt combined with the e¡ect of pro¢lin I on the
polymerization of actin with free barbed ends [29] urged us
to study the e¡ect of the peptVASPwt-pro¢lin II complex on
the polymerization of actin. First we focused on the polymer-
ization of actin with free barbed ends. In Fig. 2, we followed
the polymerization of 10 WM actin, either alone (curve A), in
the presence of 10 WM thymosin L4 (curve B), with 5 WM
pro¢lin II and 10 WM thymosin L4 (curve C) or with the
pre-incubated mixture of 5 WM pro¢lin II and 5 WM pept-
VASPwt added to the G-actin-thymosin L4 mixture (curve D).
As expected, we observed a reduced and decelerated actin
polymerization in the presence of thymosin L4 due to the
inhibition of both actin nucleation and polymerization by
thymosin L4 (curve B). When pro¢lin II was added to this
reaction mixture (curve C), a stronger inhibitory e¡ect was
displayed because of the sequestering of G-actin by both pro-
teins, consistent with the ¢ndings of Pantaloni and Carlier [28]
who found similar e¡ects for pro¢lin I and thymosin L4. Sur-
prisingly, pro¢lin II pre-incubated with peptVASPwt, at con-
centrations where a signi¢cant amount of complex is formed,
fully restores actin polymerization in the presence of thymosin
L4 (compare curves D and A with C). Remarkably also the
nucleation period seems to be a little bit shorter (Fig. 2, inset).
Both these e¡ects cannot be attributed to an interaction be-
tween actin and the peptide because the polymerization curve
of actin pre-incubated with peptVASPwt alone (curve not
shown) coincides with the polymerization curve of actin alone.
One could argue that the binding of the peptVASPwt to
pro¢lin II prevents the latter from interacting with G-actin,
hence pro¢lin II could no longer sequester G-actin and con-
sequently actin polymerization would be less inhibited (com-
pared to the reaction without peptide). Three lines of evidence
indicate this is not the case. First, we observed that the poly-
merization curve of actin in the presence of pro¢lin II, thy-
mosin L4 and the peptide (Fig. 2, curve D) reaches equi-
librium at a higher value than the polymerization curve of
FEBS 21761 22-3-99
Fig. 3. peptVASPwt does not alter the a⁄nity of pro¢lin II for actin. A: F-actin was capped with gelsolin (gelsolin:actin ratio 1:330) and di-
luted into F-bu¡er to the concentration indicated on the X-axis. Curve A (R) represents the actin control curve, in curve B (E) actin was incu-
bated with 3 WM pro¢lin II and in curve C (F) with 3 WM pro¢lin II and 3 WM peptVASPwt. B: 4 WM F-actin (5.5% pyrene labeled) was
capped with 12 nM gelsolin (1:330) and incubated with peptVASPwt, in a concentration range from 0 WM to 100 WM, in the absence (curve
A, a) or in the presence of 3 WM pro¢lin II (curve B, b).
Fig. 4. Pro¢lin I, in the presence of peptVASPwt, does not restore
on actin polymerization. We monitored the polymerization of either
10 WM actin alone (curve A, R), in the presence of 10 WM thymo-
sin L4 and 5 WM pro¢lin I (curve B, a) or in the presence of 10 WM
thymosin L4, 5 WM pro¢lin I and 5 WM peptVASPwt (curve C, b).
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actin and thymosin L4 alone (Fig. 2, curve B). Second, we
routinely observe a ternary complex between poly(L-proline),
pro¢lin and actin during puri¢cation (see for instance Fig. 5 in
[34]). Third, we performed a pro¢lin II sequestration assay (3
WM pro¢lin II, Fig. 3A) using capped actin ¢laments in the
presence of 3 WM VASP peptide, a concentration where sig-
ni¢cant amounts of peptide-pro¢lin II complexes will be
formed. If this results in less pro¢lin for sequestration of
actin, or if the pro¢lin II in complex with the VASP peptide
has a much reduced a⁄nity for actin, this would shift the
actin pro¢lin II peptide curve (curve C) towards the curve
for actin alone (curve A). This is not what we observe, adding
the VASP peptide to the reaction hardly shifts the curve,
suggesting the various pro¢lin species in the di¡erent possible
reactions have a similar a⁄nity for actin. Moreover, we car-
ried out a control experiment (Fig. 3B) in which a constant
amount of capped F-actin ¢laments, 4 WM, with a constant
amount of pro¢lin II, 3 WM, but with varying concentrations
of the VASP peptide from 0 to 100 WM, were incubated to
reach equilibrium. We observe a more or less constant value
for the pyrene £uorescence of the di¡erent samples, suggesting
that the a⁄nity of pro¢lin II for actin does not change to a
great extent when pro¢lin is in complex with the VASP pep-
tide.
We also investigated variants of peptVASPwt (Fig. 2). As
already mentioned above, actin polymerization inhibited by
thymosin L4 and pro¢lin II is restored when this peptide is
present. When we performed a similar experiment with a
shorter variant, with only one GP5 repeat, peptVASPs (curve
E), we observed no restoration of actin polymerization, likely
because of the lower a⁄nity and the lack of dimerization of
pro¢lin II on this peptide (Table 1). In the case of the peptide
with the glycine residues substituted by prolines, pept-
VASP(G/P) (curve F) we observe only partial restoration of
actin polymerization, suggesting that the presence of glycine
residues between the three proline stretches in the pept-
VASPwt may be important to mediate the e¡ect of pro¢lin
II on actin polymerization.
3.3. Actin polymerization is not restored by pro¢lin I in the
presence of peptVASPwt
We performed a similar experiment using pro¢lin I (Fig. 4).
As expected, polymerization of 10 WM actin in the presence of
5 WM pro¢lin I and 10 WM thymosin L4 is nearly completely
abolished due to combined inhibition of nucleation of poly-
merization by pro¢lin I and thymosin L4 (curve B). However,
in contrast to the results for pro¢lin II, we observe no resto-
ration of actin polymerization in the presence of 5 WM pept-
VASPwt (curve C). We explain this by the lower a⁄nity of
this pro¢lin isoform for the peptide (as evidenced by the Bia-
core experiments, Fig. 1B and Table 1), under the experimen-
tal conditions used almost no peptide-pro¢lin I complexes are
formed.
3.4. Polymerization is not restored by the pro¢lin
II-peptVASPwt complex when barbed ¢lament ends
are capped
In the model proposed by Pantaloni and Carlier [29], pro-
¢lin I-G-ATP-actin complexes participate in the polymeriza-
tion by adding to free barbed ends of actin ¢laments. If pro-
¢lin II in complex with peptVASPwt follows a similar
mechanism restoration of polymerization should not happen
when barbed ends are not available. Therefore, we incubated
gelsolin capped F-actin nuclei (10 WM actin, 40 nM gelsolin)
and followed the polymerization of actin alone (Fig. 5, curve
A), and of actin in the presence of 10 WM thymosin L4 and
5 WM of pro¢lin II without (curve B) or with (curve C) 5 WM
peptVASPwt. We observe no di¡erence between the curve
FEBS 21761 22-3-99
Fig. 6. Model for the di¡erential regulation of actin polymerization
by pro¢lin I and II. The activity of pro¢lin I (left) is under control
of phospholipase C (PLC) [54]. Upon phosphorylation of the latter,
pro¢lin I is released from the membrane and can bind G-actin. This
pro¢lin-actin complex adds onto the barbed end of uncapped ¢la-
ments, hence promoting the elongation step in the actin polymeriza-
tion cycle. Pro¢lin II (right) dimerizes with a high a⁄nity onto the
proline rich stretches of proteins. These proteins may be located in
anchor sites and linked to proteins in focal adhesion sites or in Lis-
teria tails. The dimer of pro¢lin II on these proline stretches binds
two actin monomers and promotes actin nucleation and actin elon-
gation. Some of these proline rich proteins are known to bind di-
rectly to actin [60^62]. The barbed end of the actin ¢laments is indi-
cated with (+).
Fig. 5. The peptVASPwt-pro¢lin II complex does not promote poly-
merization when barbed ends are capped. We followed the polymer-
ization of 10 WM actin capped with 40 nM gelsolin (1:250) (curve
A, R), in the presence of 10 WM thymosin L4 and 5 WM pro¢lin II
(curve B, E), and in the presence of 10 WM thymosin L4, 5 WM pro-
¢lin II and 5 WM peptVASPwt (curve C, F).
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with and without peptide, indicating pro¢lin II acts in both
cases as a pure G-actin sequestering agent (in analogy with
pro¢lin I [29]) and consequently the interaction no longer
restores actin polymerization when the barbed ends are
capped.
4. Discussion
In this paper we studied the kinetic properties of the inter-
action of pro¢lin with a proline rich peptide derived from
VASP and the e¡ect of this interaction on actin polymeriza-
tion. Using Biacore experiments, we showed that pro¢lin II
(and likely also pro¢lin I) forms dimers upon binding the
wild-type VASP peptide, peptVASPwt. For the equilibrium
dissociation constant of the interaction between pro¢lin II
and peptVASPwt we derived a value of approximately 0.5
WM. For the interaction of pro¢lin I with this peptide, we
estimate a Kd that will be higher than 120 WM, in agreement
with previous reported values for the interaction of this pro-
¢lin isoform with slightly di¡erent peptides [42,44]. The ob-
servation that stable pro¢lin II-peptVASPwt complexes can be
made, prompted us to investigate their e¡ect on actin poly-
merization. At high concentrations, pro¢lins are strong inhib-
itors of nucleation [29,45,46], an e¡ect that is augmented by
thymosin L4. Consequently, little actin polymerization occurs
(in the time frame monitored), when both these actin binding
proteins are present. However, in the presence of pept-
VASPwt, the combined capacity of pro¢lin II and thymosin
L4 to inhibit nucleation is completely abolished. This positive
e¡ect depends on the formation of pro¢lin II-peptVASPwt
complexes, because pro¢lin I, which has low a⁄nity for this
peptide, cannot restore the polymerization. Also, free barbed
ends are required, as capping of ¢laments results in normal
sequestering in the presence of pro¢lin II-peptVASPwt com-
plexes. The latter experiment also indicates that the peptide
does not change the a⁄nity of pro¢lin for actin signi¢cantly,
in agreement with data presented in Fig. 3 and with data that
demonstrate formation of ternary complexes between actin,
pro¢lin and poly(L-proline), [7,34,44,47]. From our polymer-
ization data, it appears that the nucleation and perhaps also
the elongation phases are a¡ected when peptVASPwt is
present. The latter is consistent with the known role of pro¢lin
in barbed end elongation as reported previously [27,29,46,48].
Thus, it appears that actin bound to pro¢lin II-peptVASPwt
complexes can add more e⁄ciently to plus ends of the ¢la-
ment than actin-pro¢lin II complexes. In theory, the state of
the nucleotide bound to G-actin could also in£uence the re-
action, as pro¢lin is known to catalyze the exchange of ADP
for ATP, [49,50]. We expect this e¡ect will be of minor in£u-
ence in our experiments as we start with ATP-actin and no
signi¢cant treadmilling occurs at the initial stages of polymer-
ization.
We sought to explain this enhanced polymerization medi-
ated by the pro¢lin II-peptVASPwt complexes in a structural
way. Therefore, we modeled a pro¢lin II dimer on the peptide
using the published crystal structure of the pro¢lin I-L-Pro10
complex [43]. We then ¢tted this model to the ribbon [51] or
¢lament model of actin [52], using the pro¢lin I-actin structure
as a template [51]. In neither case do the structural models
allow one to explain why the pro¢lin II-peptide complex re-
sults in more e⁄cient polymerization. However, we note that
the pro¢lin molecules in the pro¢lin I-L-Pro10 complex do not
interact [43]. In contrast, our Biacore data are suggestive of
co-operative binding of pro¢lin II to the peptVASPwt, neces-
sitating pro¢lin II molecules to interact with each other. In
addition, peptVASPwt may have a less rigid structure than L-
Pro10 due to the presence of the glycine residues. These appear
to play a role in the bene¢cial e¡ect on actin polymerization
because the peptide composed of 17 proline residues, pept-
VASP(G/P), only partially restores actin polymerization
(Fig. 2A, curve F). However, the a⁄nity of pro¢lin II for
this peptide is slightly reduced. In contrast, pro¢lin I binds
better to polyproline peptides of de¢ned length than to their
counterparts containing glycines [42]. The importance of the
glycine residues also follows from an observation by Kang et
al. [53], who studied Listeria motility. They reported an in-
hibition of motility, due to competitive blocking of VASP-
binding to pro¢lin, when they injected a GP5GP5GP5 peptide
into Listeria infected PtK2 cells but not when a pure poly(L-
proline) peptide was used.
The results presented in this paper combined with the al-
ready known di¡erent a⁄nities of the di¡erent pro¢lin iso-
forms for PIP2 and proline rich proteins [35] allow us to
present a model (Fig. 6) that provides insight into the relation
between actin based motility and the pro¢lin isoforms. Pro¢-
lin I is known to be preferentially associated with PIP2 [35]
and under this condition cannot bind actin nor promote actin
polymerization [8]. Upon activation, phospholipase C is phos-
phorylated and hydrolyzes PIP2 causing the release of pro¢lin
I from membranes [54]. This pro¢lin isoform can then mod-
ulate the actin polymerization cycle [54] depending on the
status of the plus end of the ¢lament. In contrast, pro¢lin II
can be recruited by proteins containing proline stretches of
su⁄cient length [35,42,44] such as VASP and Mena, localized
in focal adhesions [13,15] or in the tail of Listeria [15,55,56].
Since VASP and presumably also the other Ena/VASP family
proteins are oligomeric [12,57], this may result locally in high
concentrations of the dimeric form of pro¢lin II. This form
may then help in more e⁄cient nucleation of actin polymer-
ization and elongation because our data show that rapid pol-
ymerization via the barbed end can be initiated by pro¢lin
bound to proline rich sequences. This may co-operate with
the modest nucleation activity of the Arp 2/3 complex as
this complex operates at the opposite end of the ¢lament
[58,59]. The e¡ect we observe may be more complex with
the intact proteins as several of these, like VASP and
WASP related proteins, have been shown also to bind directly
to actin [60^62] and this will complicate kinetics. Proline rich
proteins are under control of regulation, VASP is a target of
cAMP and cGMP dependent kinases [63] and Mena binds
SH3 domains [15]. WASP [64], Diaphanous [23] and
Bni [16,17] are under control of small GTPases. Future ex-
periments will show if any of these types of ligands regulate
dimer formation of pro¢lin II coupled to enhanced polymer-
ization.
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